Ahmed Shelbaya, MD

Senior Director Global Health Outcomes Research, Pfizer

Professor Alan Boyd (FPM)

Past President of the Faculty of Pharmaceutical Medicine, CEO & Founder of Boyds and Consultant Pharmaceutical Physician

Amber Whybro

Senior Director Clinical Operations UK & Ireland at Quintiles

Ana B. Salgado

Director, Strategic Planning

Global Pharma, Consultant & Advisor

Anna Van Troostenburg De Bruyn

EU QPPV and VP Pharmacovigilance & Epidemiology at Gilead Sciences

Beate Schmidt, MSc, MDRA, RAC

Freelance regulatory consultant to the pharma and biotech industry

Dr. Bill Lam

Director, Clinical Site Management - Australia/NZ/South Africa at Pfizer

Brenda Raphael

Senior Vice President, General Manager Bayer Consumer

Brian Gennery, MBE, FRCP, FFPM

Visiting Professor, Institute of Pharmaceutical Sciences at King’s College London

Carl Naraynassamy

Visiting Senior Lecturer, King’s College London

Christine Carberry

Certified Strategic Alliance Professional

Dr. Christopher-Paul Milne

Retired Director of Research at Tufts CSDD

Daniel García Molinero

Senior Regulatory Manager at Drug Development and Regulation (DDR)

David Morgan, MA, MSc, CStat, CMath

Statistical Consultant

David Raunig, Ph.D.

Sr. Principal Imaging Statistician at ERT

Domenico Criscuolo, MD, PhD

Past President of the Italian Association of Pharmaceutical Medicine) and IFAPP, Italian SMD Team Lead

Dominique Dubois, MD, FBCPM, FFPM

Editor-in-Chief of Frontiers in Pharmaceutical Medicine & Outcomes Research

Edward Power PhD, MBA

Vice President, North America Medical Affairs, Hospital Business at Pfizer

Greg Koski, PhD, MD

Co-Founder at Alliance for Clinical Research Excellence and Safety, ACRES

Helene Schluep, MD

Global Medical Affairs, Pfizer

Jacqui Piner, PhD

Scientific Director, GSK, GSK Fellow

Javier Coindreau

Vice-President Global Medical Affairs at Gilead Sciences

Jeffrey Cohen

Principal, Performance Leaders, LLC

Jeff Duke, M.Sc, C.Chem, C.Sci, FRSC

Consultant, Grove Lodge Consulting

John Alter

VP, Patient and Health Impact Lead, Hospital Business Unit at Pfizer

John M. Kelton, Pharm.D.

US Medical Director, Oncology Biosimilars Pfizer

Dr. Juliana (Judith) Hey-Hadavi

Global Medical Lead for Sterile Injectables Director, Hospital BU, Pfizer New York HQ

Dr. Kamlesh Thakker PhD, MBA

Principal at Notting Hill Consulting LLC

Kenneth I Kaitin, PhD

Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Laurent Pacheco MD, MBA, MSC, MHSA, PhD (Econ.)

Life Sciences Head (London), BearingPoint

Larry Kennedy, PhD

CEO, Quality Management Institute; Co-Founder and V.P Quality Management Systems, ACRES ReServ

Lisa Egbuonu-Davis MD, MPH, MBA

VP, Medical Innovations, DH Diagnostics, LLC, a Danaher company

Mike Collins Ph.D., CStat

Owner at Mike Collins Consulting LLC

Nikolas Karkanias, Ph.D.

Senior Director, Field Based Medical Lead for Oncology Biosimilars in the U.S., Pfizer

Dr. Omar Antonio Alvarez-Pousa

Information Technology Services Director at Zoetis Inc. (former Pfizer Animal Health) ; New York University Professor

Otfried Kistner, Ph.D.

Senior Consultant & Independent Vaccine Expert

Paula Tully

Principal, Escentia, Ltd.

Peter Šajben, MD

Vice President, Regional Head Medical Affairs, Africa & Middle East Region, Pfizer Essential Health

Petra Dörr, PhD

Executive Director at Petra Doerr Consulting Ltd, former Deputy Executive Director at Swissmedic, Switzerland

Pol Vandenbroucke, MD, MSc, MBA, FFPM

Chief Medical Officer Pfizer Hospital Business Unit

Pravin Chopra, MD

Independent Global Life Sciences Medical Executive

Dr. Rory O’Connor

SVP, Chief Medical Officer, Internal Medicine, Pfizer Innovative Health

Professor Sam S Salek, RPh, PhD, FFPM, GFMD, FRPS, FESCP, MCMS

School of Life & Medical Sciences, University of Hertfordshire, United Kingdom

Sandor Kerpel-Fronius, M.D., D.Sc.

Professor of Clinical Pharmacology. Department of Pharmacology and Pharmacotherapy. Semmelweis Medical University. Budapest, Hungary

Seema Haider, PhD

Senior Director, Team Lead Global Established Products & Biosimilars, Outcomes & Evidence at Pfizer

Shayesteh Fürst-Ladani, MSc, MBA

CEO of SFL Group of Companies

Shoibal Mukherjee, MD, DM

VP & Head, Asia Medical Sciences Group at Quintiles

Soneil Guptha, MD, FACC, FESC, AFPM

Independent pharmaceutical physician and consultant in pharmaceutical medicine (Drug & Device Development and Drug Regulation)

Susy Davis

Director, SLD Solutions Ltd

Syed Kazmi, PhD, MBA

Vice President, Global Head Business Development & Licensing, Novartis Oncology

Tamás Sütő MD, PhD, MICR (Sanofi)

Global Head of Medical Capability Development, Sanofi

Tony Fox, MSc, MBBS, MD(Lond)

Manging Director / President at EBD London Ltd / EBD Consulting Inc, Nevada

Xavier Luria, MD

Independent consultant on Drug Development and Drug Regulation, located in Barcelona and London

Zaide Frias, MBA

Head of Regulatory Affairs at EMEA

IFAPP Academy Faculty